Taurolidine
CAS No. 19388-87-5
Taurolidine( —— )
Catalog No. M20835 CAS No. 19388-87-5
Taurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions.?It displays broad bactericidal and fungicidal activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 42 | Get Quote |
|
50MG | 67 | Get Quote |
|
100MG | 102 | Get Quote |
|
200MG | 151 | Get Quote |
|
500MG | 255 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTaurolidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTaurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions.?It displays broad bactericidal and fungicidal activity.
-
DescriptionTaurolidine is a synthetic taurine analog with antimicrobial and anti-neoplastic actions.?It displays broad bactericidal and fungicidal activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCancer
-
IndicationColorectal Cancer; Periodontitis
Chemical Information
-
CAS Number19388-87-5
-
Formula Weight284.36
-
Molecular FormulaC7H16N4O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:56mg/mL(196.93mM)
-
SMILESO=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mccourt M Wang J H Sookhai S et al. Taurolidine Inhibits Tumor Cell Growth In Vitro and In Vivo[J]. Annals of Surgical Oncology 2000 7(9):685-691.
molnova catalog
related products
-
p-Cresyl sulfate
The p-Cresol is a protein-bound uremic retention solute. Free p-Cresol was found to be a cardiovascular risk factor in non-diabetic hemodialysis patients.
-
Compound EN300-73745...
Compound EN300-7374549(BB) is a Building Block.
-
2-Hydroxy-3-methylbu...
2-Hydroxy-3-methylbutyric acid (2-hydroxyisovaleric acid) is a metabolite found in the urine of patients with phenylketonuria methylmalonic acidemia propionic acidemia 3-ketothiolase deficiency isovaleric acidemia 3-methylcrotonylglycemia 3-hydroxy-3-methylglutaric acidemia multiple carboxylase deficiency glutaric aciduria ornithine transcarbamylase deficiency glyceroluria tyrosinemia type I galactosemia and maple syrup urine disease.